Intrathecal interleukin-6 levels are associated with progressive disease and clinical severity in multiple sclerosis
IL-6 in CSF indicates ongoing CNS inflammation and may contribute to the compartmentalized inflammation associated with disease progression and overall disease severity.
Authors
- Justine Itorralba (ORCID: https://orcid.org/0000-0002-8578-2771)
- Koroboshka Brand‐Arzamendi
- Alexandra Muccilli
- Georges Saab
- Raphaël Schneider (ORCID: https://orcid.org/0000-0003-1776-2418)
Institutions
- University of Toronto (CA)
- St. Peter's Hospital (CA)
- St Michael's Hospital (GB)
- University of Manitoba (CA)
Publication Details
- Journal
- BMC Neurology
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1186/s12883-025-04145-0
- Citations
- 2
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.94